Prospective Evaluation of Fetuses With Autoimmune-Associated Congenital Heart Block Followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study

We evaluated the efficacy of dexamethasone (DEX) in anti-SSA/Ro–exposed fetuses newly diagnosed with congenital heart block. Previous use of DEX has been anecdotal with varying reports of therapeutic benefit. This was a multicenter, open-label, nonrandomized study involving 30 pregnancies treated wi...

Full description

Saved in:

Bibliographic Details
Published in:	The American journal of cardiology Vol. 103; no. 8; pp. 1102 - 1106
Main Authors:	Friedman, Deborah M., MD, Kim, Mimi Y., ScD, Copel, Joshua A., MD, Llanos, Carolina, MD, Davis, Claudine, BS, Buyon, Jill P., MD
Format:	Journal Article
Language:	English
Published:	New York, NY Elsevier Inc 15-04-2009 Elsevier Elsevier Limited
Subjects:	Adolescent Adult Autoantigens - immunology Autoimmune diseases Autoimmune Diseases - complications Autoimmune Diseases - immunology Biological and medical sciences Cardiac dysrhythmias Cardiology Cardiology. Vascular system Cardiovascular Cardiovascular disease Dexamethasone - therapeutic use Drugs Female Fetal Diseases Fetuses Glucocorticoids - therapeutic use Heart Heart Block - congenital Heart Block - drug therapy Heart Block - immunology Humans Medical sciences Peptide Fragments - immunology Pregnancy Prospective Studies Ribonucleoproteins - immunology Young Adult Autoimmunity Evaluation Dexamethasone Arrhythmia Congenital PR interval Cardiovascular disease Conduction disorder Prospective Heart disease Heart block Fetus Circulatory system Cardiology
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!